Nitro-bid and Pantoprazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Nitro-bid (nitroglycerin) and Pantoprazole (pantoprazole sodium). Common drug interactions include death among females and hypotension among males.
The phase IV clinical study analyzes what interactions people have when they take Nitro-bid and Pantoprazole. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Nitro-bid?
Nitro-bid has active ingredients of nitroglycerin. eHealthMe is studying from 653 Nitro-bid users. Check the latest studies of Nitro-bid.
What is Pantoprazole?
Pantoprazole has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 285,170 Pantoprazole users. Check the latest studies of Pantoprazole.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
27 people who take Nitro-bid and Pantoprazole together, and have interactions are studied.

What are the common drug interactions of Nitro-Bid and Pantoprazole, by gender? *:
female:
- Death
- Dementia (madness)
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Device related infection
- Drug hypersensitivity
- Fatigue (feeling of tiredness)
- Hallucination (an experience involving the perception of something not present)
- Hyperhidrosis (abnormally increased sweating)
- Hypotension (abnormally low blood pressure)
- Insomnia (sleeplessness)
male:
- Hypotension (abnormally low blood pressure)
- Lethargy (tiredness)
- Asthenia (weakness)
- Chest pain
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Decreased appetite
- Dizziness
- Hepatic failure (liver failure)
- Hypertensive crisis
- Insomnia (sleeplessness)
What are the common drug interactions of Nitro-Bid and Pantoprazole, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Dyspnoea (difficult or laboured respiration)
- Cystic fibrosis (disease of the secretary glands)
- Disease complication
- Lung disorder (lung disease)
30-39:
n/a
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Chronic kidney disease
- Decreased activity
- Depression
- Emotional distress
- Pain
- Renal failure (kidney dysfunction)
- Renal impairment (severely reduced kidney function)
50-59:
- Fall
- Gallbladder disorder
- Haematuria (presence of blood in urine)
- Intervertebral disc degeneration (spinal disc degeneration)
- Intervertebral disc protrusion (spinal disc protrusion)
- Irritable bowel syndrome
- Lumbar radiculopathy (radicular pain in the low back and legs)
- Lung neoplasm malignant (cancer tumour of lung)
- Multiple fractures
- Muscle fatigue (a condition in which muscles cannot exert their normal force)
60+:
- Diarrhoea
- Hypotension (abnormally low blood pressure)
- Decreased appetite
- Dementia (madness)
- Device related infection
- Dizziness
- Encephalopathy (functioning of the brain is affected by some agent or condition)
- Hallucination (an experience involving the perception of something not present)
- Hyperhidrosis (abnormally increased sweating)
- Hypertensive crisis
What are the existing conditions these people have? *
- Stress And Anxiety: 5 people, 18.52%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 14.81%
- High Blood Cholesterol: 3 people, 11.11%
- Cystic Fibrosis (disease of the secretary glands): 3 people, 11.11%
- Pain: 2 people, 7.41%
- Muscle Spasms (muscle contraction): 2 people, 7.41%
- Insomnia (sleeplessness): 2 people, 7.41%
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 7.41%
- Hypotension (abnormally low blood pressure): 2 people, 7.41%
- High Blood Pressure: 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Nitro-bid and Pantoprazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Nitro-bid (653 reports)
- Pantoprazole (285,170 reports)
Browse all drug interactions of Nitro-bid and Pantoprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Nitro-bid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Pantoprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nitro-bid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pantoprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on nitroglycerin and pantoprazole sodium (the active ingredients of Nitro-bid and Pantoprazole, respectively), and Nitro-bid and Pantoprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Flexeril cause Withdrawal Syndrome? - 3 seconds ago
- Could Miralax cause Vitreous Detachment? - 5 seconds ago
- Could Trileptal cause Dental Caries? - 6 seconds ago
- Could Tresiba cause Vision Blurred? - 9 seconds ago
- Could Actemra cause Pneumonia Pneumococcal? - 13 seconds ago
- Could Actemra cause Blindness Transient? - 18 seconds ago
- Could Itraconazole cause Infusion Related Reaction? - 20 seconds ago
- Could Methotrexate cause Cervicitis? - 22 seconds ago
- Could Valtrex cause Tricuspid Valve Incompetence? - 22 seconds ago
- Drug interactions of Pentam and Tramadol - 26 seconds ago